Earnings Call · Q2 FY2025·2025-07-23

Q2 25EPS -31.82%·Rev n/aQ1 25EPS -32.26%·Rev n/aQ4 24EPS -18.52%·Rev n/aQ3 24EPS +8.33%·Rev n/a⚠ consensus missing

Viking Therapeutics, Inc. VKTX

Stephanie Diaz — Manager of Investor Relations

Brian Lian — President & CEO

Gregory Zante — Chief Financial Officer

+4.0%1d on move date+3.2% vs SPY3d+7.2%5d+2.5%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more VKTX calls or request research access.

More VKTX calls Browse calls Request research access